LABP - Landos Biopharma - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

LABP is currently covered by 1 analysts with an average price target of $36.32. This is a potential upside of $13.39 (58.4%) from yesterday's end of day stock price of $22.93.

Landos Biopharma's activity chart (see below) currently has 1 price targets and 2 ratings on display. The stock rating distribution of LABP is 100% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 33.33% with an average time for these price targets to be met of 132.43 days.

Highest price target for LABP is $20.42, Lowest price target is $20.42, average price target is $36.32.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 01-Apr-2024. First documented stock forecast 01-Mar-2021.

Currently out of the existing stock ratings of LABP, 1 are a HOLD (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$20.42

$-2.51 (-10.95%)

$500

11 months 2 days ago
(01-Apr-2024)

0/2 (0%)

$-1.18 (-5.46%)

Sell

$14

2 years 1 months 25 days ago
(06-Jan-2023)

1/2 (50%)

$2 (16.67%)

713

Hold

$3

2 years 3 months 20 days ago
(11-Nov-2022)

1/3 (33.33%)

$-7.6 (-71.70%)

87

Buy

2 years 6 months 19 days ago
(12-Aug-2022)

0/1 (0%)

$167.4 (102.95%)

Hold

$15

$8.43 (128.31%)

$170

3 years 2 months ago
(03-Jan-2022)

1/2 (50%)

$-37.2 (-71.26%)

64

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is LABP (Landos Biopharma) average time for price targets to be met?

On average it took 132.43 days on average for the stock forecasts to be realized with a an average price target met ratio 33.33

Which analyst has the current highest performing score on LABP (Landos Biopharma) with a proven track record?

REUBEN GARNER

Which analyst has the current lower performing score on LABP (Landos Biopharma) with a proven track record?

RAGHURAM SELVARAJU

Which analyst has the most public recommendations on LABP (Landos Biopharma)?

Reuben Garner works at BENCHMARK and has 14 price targets and 16 ratings on LABP

Which analyst is the currently most bullish on LABP (Landos Biopharma)?

Reuben Garner with highest potential upside - $41.62

Which analyst is the currently most reserved on LABP (Landos Biopharma)?

Raghuram Selvaraju with lowest potential downside - -$2.51

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?